within Pharmacolibrary.Drugs.N_NervousSystem.N02C_AntimigrainePreparations.N02CA02_Ergotamine;

model Ergotamine
  extends Pharmacolibrary.Drugs.ATC.N.N02CA02;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>N02CA02</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Ergotamine is an ergot alkaloid used for the acute treatment of migraine attacks and cluster headaches. It is a vasoconstrictor and acts by stimulating alpha-adrenergic and serotonergic (5-HT1) receptors. Use of ergotamine has declined due to the availability of triptans and its side effect profile. It is currently approved in some countries but less commonly used.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported for healthy adult volunteers, both sexes, following a single oral dose.</p><h4>References</h4><ol><li><p>Lipton, RB, et al., &amp; Albrecht, D (2025). Relationship of dihydroergotamine pharmacokinetics, clinical efficacy, and nausea-A narrative review. <i>Headache</i> 65(3) 527–535. DOI:<a href=\"https://doi.org/10.1111/head.14877\">10.1111/head.14877</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/39601088/\">https://pubmed.ncbi.nlm.nih.gov/39601088</a></p></li><li><p>Shrewsbury, SB, et al., &amp; Weinstein, S (2008). Randomized, double-blind, placebo-controlled study of the safety, tolerability and pharmacokinetics of MAP0004 (orally-inhaled DHE) in adult asthmatics. <i>Current medical research and opinion</i> 24(7) 1977–1985. DOI:<a href=\"https://doi.org/10.1185/03007990802160677\">10.1185/03007990802160677</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/18534051/\">https://pubmed.ncbi.nlm.nih.gov/18534051</a></p></li><li><p>Lavène, D, et al., &amp; Guillevin, L (1985). Hydergine pharmacokinetics in the elderly. <i>Journal de pharmacologie</i> 16 Suppl 3 135–143. PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/4094443/\">https://pubmed.ncbi.nlm.nih.gov/4094443</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial generated model</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end Ergotamine;
